Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterocyclic compounds as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Heterocyclic compounds as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

US Patent 8653059 · Granted Feb 18, 2014

Estimated economic value: $166,154,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Glucose-responsive insulin conjugates2025
Inhibitors of fibroblast growth factor receptor kinases2025
NK3 modulators and uses thereof2025
4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activi2025
Cyclobutyl pyrazolopyrimidine PDE9 inhibitors2025
2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors2025
Inhibitors of MEK kinase2024
Bottle2024
AMPK activators2023
Conjugate based systems for controlled insulin delivery2023
Inhibtors of Raf kinases2023
2-oxoimidazolidine-4-carboxamides as NAv1.8 inhibitors2023